Independence of measles-specific humoral and cellular immune responses to vaccination.

[1]  R. Vierkant,et al.  Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. , 2011, Vaccine.

[2]  W. Moss,et al.  Biological Feasibility of Measles Eradication , 2012 .

[3]  V. Pankratz,et al.  A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. , 2011, Vaccine.

[4]  R. Vierkant,et al.  The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity , 2011, Human Genetics.

[5]  M. Slifka,et al.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans. , 2011, Virology.

[6]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.

[7]  R. Vierkant,et al.  Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. , 2009, Journal of immunological methods.

[8]  Stephen L. Cochi,et al.  Global measles mortality, 2000-2008. , 2009, MMWR. Morbidity and mortality weekly report.

[9]  W. Moss.  Measles Control and the Prospect of Eradication , 2009, Current topics in microbiology and immunology.

[10]  J. Blostein.  Global measles outbreaks threaten US. , 2008, Michigan medicine.

[11]  Development of a Novel Efficient Fluorescence-Based Plaque Reduction Microneutralization Assay for Measles Virus Immunity , 2008, Clinical and Vaccine Immunology.

[12]  R. Vierkant,et al.  HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses. , 2007, Virology.

[13]  W. Moss,et al.  Can we eradicate measles , 2006 .

[14]  R. Vierkant,et al.  Correlations among measles virus‐specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles–mumps–rubella‐II (MMR‐II) vaccination , 2005, Clinical and experimental immunology.

[15]  G. Poland,et al.  Detection of Measles Virus-Specific Interferon-γ-Secreting T-Cells by ELISPOT , 2005 .

[16]  G. Poland,et al.  Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT. , 2005, Methods in molecular biology.

[17]  P. Strebel,et al.  Measles Vaccines and the Potential for Worldwide Eradication of Measles , 2004, Pediatrics.

[18]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[19]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[20]  S. Davey.  Measles eradication still a long way off. , 2001, Bulletin of the World Health Organization.

[21]  F. Polack,et al.  Production of atypical measles in rhesus macaques: Evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody , 1999, Nature Medicine.

[22]  J. Yewdell,et al.  Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. , 1999, Advances in immunology.

[23]  B. Ward,et al.  Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. , 1995, The Journal of infectious diseases.

[24]  C. Biron.  Cytokines in the generation of immune responses to, and resolution of, virus infection. , 1994, Current opinion in immunology.

[25]  L. Kaplan,et al.  Severe measles in immunocompromised patients. , 1992, JAMA.

[26]  T. Mosmann.  Cytokine secretion patterns and cross-regulation of T cell subsets , 1991, Immunologic research.

[27]  K. Pulford,et al.  The distribution of immunoreactive interferon-alpha in normal human tissues. , 1989, Immunology.

[28]  R. Coffman,et al.  Heterogeneity of cytokine secretion patterns and functions of helper T cells. , 1989, Advances in immunology.

[29]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[30]  L. Markowitz,et al.  Fatal measles pneumonia without rash in a child with AIDS. , 1988, The Journal of infectious diseases.

[31]  S. Specter,et al.  Clinical virology manual , 1986 .

[32]  J. Devogelaer,et al.  ETIDRONATE AND THE RISK OF FRACTURES , 1985, The Lancet.

[33]  F. Burnet.  Measles as an index of immunological function. , 1968, Lancet.

[34]  A. Evans,et al.  Attenuated measles vaccine in children with acute leukemia. , 1962, American journal of diseases of children.